Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BALLESTA AM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 74 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Alvarez, L; Guanabens, N; Peris, P; Vidal, S; Ros, I; Monegal, A; Bedini, JL; Deulofeu, R; Pons, F; Munoz-Gomez, J; Ballesta, AM
      Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease

      BONE
    2. Filella, X; Molina, R; Alcover, J; Coca, F; Zarco, MA; Ballesta, AM
      Influence of AFP, CEA and PSA on the in vitro production of cytokines

      TUMOR BIOLOGY
    3. Garcia-Carrasco, M; Font, J; Filella, X; Cervera, R; Ramos-Casals, M; Siso, A; Aymami, A; Ballesta, AM; Ingelmo, M
      Circulating levels of Th1/Th2 cytokines in patients with primary Sjogren'ssyndrome: Correlation with clinical and immunological features

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    4. Pares, A; Guanabens, N; Alvarez, L; De Osaba, MJM; Oriola, J; Pons, F; Caballeria, L; Monegal, A; Salvador, G; Jo, J; Peris, P; Rivera, F; Ballesta, AM; Rodes, J
      Collagen type I alpha I and vitamin D receptor gene polymorphisms and bonemass in primary biliary cirrhosis

      HEPATOLOGY
    5. Alvarez, L; Ricos, C; Peris, P; Guanabens, N; Monegal, A; Pons, F; Ballesta, AM
      Components of biological variation of biochemical markers of bone turnoverin Paget's bone disease

      BONE
    6. Peris, P; Alvarez, L; Oriola, J; Guanabens, N; Monegal, A; de Osaba, MJM; Jo, J; Pons, F; Ballesta, AM; Munoz-Gomez, J
      Collagen type I alpha 1 gene polymorphism in idiopathic osteoporosis in men

      RHEUMATOLOGY
    7. Filella, X; Alcover, J; Zarco, MA; Beardo, P; Molina, R; Ballesta, AM
      Analysis of type T1 and T2 cytokines in patients with prostate cancer

      PROSTATE
    8. Filella, X; Alcover, J; Molina, R; Corral, JM; Carretero, P; Ballesta, AM
      Measurement of complexed PSA in the differential diagnosis between prostate cancer and benign prostate hyperplasia

      PROSTATE
    9. Menendez, V; Filella, X; Alcover, JA; Molina, R; Mallafre, JM; Ballesta, AM; Talbot-Wright, R
      Usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for transtional cell carcinoma of the bladder

      ANTICANCER RESEARCH
    10. Deulofeu, R; Pares, A; Rubio, M; Gasso, M; Roman, J; Gimenez, A; Varela-Moreiras, G; Caballeria, J; Ballesta, AM; Mato, JM; Rodes, J
      S-adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured rats

      CLINICAL SCIENCE
    11. Enjuto, M; Francino, A; Navarro-Lopez, F; Viles, D; Pare, JC; Ballesta, AM
      Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in beta-myosin heavy chain gene

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    12. Peris, P; Alvarez, L; Monegal, A; Guanabens, N; Duran, M; Pons, F; De Osaba, MJM; Echevarria, M; Ballesta, AM; Munoz-Gomez, J
      Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy

      BONE
    13. Filella, X; Alcover, J; Quinto, L; Molina, R; Bosch-Capblanch, X; Carretero, P; Ballesta, AM
      Evaluation of a multivariate prostate-specific antigen and percentage of free prostate-specific antigen logistic regression model in the diagnosis ofprostate cancer

      TUMOR BIOLOGY
    14. Molina, R; Jo, J; Filella, X; Zanon, G; Farrus, B; Munoz, M; Latre, ML; Pahisa, J; Velasco, M; Fernandez, P; Estape, J; Ballesta, AM
      C-erbB-2 CEA and CA 15.3 serum levels in the early diagnosis of recurrencein breast cancer patients

      ANTICANCER RESEARCH
    15. Molina, R; Farrus, B; Filella, X; Jo, J; Zanon, G; Pahisa, J; Latre, M; Munoz, M; Ballesta, AM
      Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse

      ANTICANCER RESEARCH
    16. Casals, E; Aibar, C; Martinez, JM; Borrell, A; Soler, A; Ojuel, J; Ballesta, AM; Fortuny, A
      First-trimester biochemical markers for Down syndrome

      PRENATAL DIAGNOSIS
    17. Alvarez, L; Peris, P; Bedini, JL; Pares, A; Monegal, A; Guanabens, N; Mas, E; Aibar, C; Ballesta, AM
      High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: Relevance as a marker of bone resorption in jaundiced patients

      CALCIFIED TISSUE INTERNATIONAL
    18. Pons, F; Alvarez, L; Peris, P; Guanabens, N; Vidal-Sicart, S; Monegal, A; Pavia, J; Ballesta, AM; Munos-Gomez, J; Herranz, R
      Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity

      NUCLEAR MEDICINE COMMUNICATIONS
    19. Net, M; Garcia-Valdecasas, JC; Deulofeu, R; Gonzalez, X; Palacin, J; Almenara, R; Valero, R; Lopez-Boado, M; Angas, J; Elena, M; Ballesta, AM; Visa, J
      S-adenosyl L-methionine effect on hepatic allografts procured from non-heart-beating donor pigs

      TRANSPLANTATION PROCEEDINGS
    20. Alvarez, L; Guanabens, N; Peris, P; Ballesta, AM
      Clinical usefulness of biochemical markers of bone turnover

      MEDICINA CLINICA
    21. Alvarez, L; Oriola, J; Jo, J; Ferro, T; Pons, F; Peris, P; Guanabens, N; Duran, M; Monegal, A; de Osaba, MJM; Rivera-Fillat, F; Ballesta, AM
      Collagen type I alpha 1 gene Sp1 polymorphism in premenopausal women with primary osteoporosis: Improved detection of Sp1 binding site polymorphism in the collagen type 1 gene.

      CLINICAL CHEMISTRY
    22. NET M; GARCIAVALDECASAS JC; DELOFEU R; PALACIN J; ELENA M; ALMENARA R; GONZALEZ X; BOADO ML; VALERO R; RULL R; BELTRAN J; BALLESTA AM; VISA J
      ROLE OF S-ADENOSYL-L-METHIONINE ON LIVER ISCHEMIA-REPERFUSION INJURY

      Molecular biology of the cell
    23. Filella, X; Blade, J; Montoto, S; Molina, R; Coca, F; Montserrat, E; Ballesta, AM
      Impaired production of interleukin 6 and tumour necrosis factor alpha in whole blood cell cultures of patients with multiple myeloma

      CYTOKINE
    24. GUANABENS N; PARES A; ALVAREZ L; DEOSABA MJM; MONEGAL A; PERIS P; BALLESTA AM; RODES J
      COLLAGEN-RELATED MARKERS OF BONE TURNOVER REFLECT THE SEVERITY OF LIVER FIBROSIS IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS

      Journal of bone and mineral research
    25. FILELLA X; ALCOVER J; MOLINA R; CARRETERO P; BALLESTA AM
      CLINICAL USEFULNESS OF PSA IN THE EARLY DIAGNOSIS OF PROSTATE-CANCER

      The Cancer journal
    26. PARES A; GUANABENS N; ALVAREZ MDL; JO J; PONS F; DEOSABA MJM; MONEGAL A; CABALLERIA L; SALVADOR G; PERIS P; BALLESTA AM; RODES J
      COLLAGEN I(ALPHA)1 SP1 POLYMORPHISM AND BONE MASS IN PRIMARY BILIARY-CIRRHOSIS

      Hepatology
    27. MIRET C; FONT J; MOLINA R; FILELLA X; VIVANCOS J; MUNOZRODRIGUEZ FJ; CERVERA R; BALLESTA AM; INGELMO M
      LACK OF CORRELATION BETWEEN TUMOR-MARKERS (CA-125 AND SCC) AND SYSTEMIC LUPUS-ERYTHEMATOSUS ACTIVITY

      Anticancer research
    28. MOLINA R; SEGUI MA; CLIMENT MA; BELLMUNT J; ALBANELLI J; FERNANDEZ M; FILELLA X; JO J; GIMENEZ N; IGLESIAS E; MIRALLES M; ALONSO C; PEIRO G; PEREZPICANOL E; BALLESTA AM
      P53 ONCOPROTEIN AS A PROGNOSTIC INDICATOR IN PATIENTS WITH BREAST-CANCER

      Anticancer research
    29. VINOLAS N; MOLINA R; GALAN MC; CASAS F; CALLEJAS MA; FILELLA X; GRAU JJ; BALLESTA AM; ESTAPE J
      TUMOR-MARKERS IN RESPONSE MONITORING AND PROGNOSIS OF NONSMALL CELL LUNG-CANCER - PRELIMINARY-REPORT

      Anticancer research
    30. Molina, R; Jo, J; Filella, X; Zanon, G; Pahisa, J; Munoz, M; Farrus, B; Latre, ML; Escriche, C; Estape, J; Ballesta, AM
      c-erbB-2 oncoprotein, CEA, and CA15.3 in patients with breast cancer: prognostic value

      BREAST CANCER RESEARCH AND TREATMENT
    31. SANLLEHY C; CASALS E; RODRIGUEZVILLAR C; ZAMBON D; OJUEL J; BALLESTA AM; ROS E
      LACK OF INTERACTION OF APOLIPOPROTEIN-E PHENOTYPE WITH THE LIPOPROTEIN RESPONSE TO LOVASTATIN OR GEMFIBROZIL IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA

      Metabolism, clinical and experimental
    32. ELENA M; PEREZ M; JANSA M; DEULOFEU R; ESMATJES E; SCHINCA N; MAS E; MOLINA R; BALLESTA AM
      CONTENT OF CARBOHYDRATES AND TRACE-ELEMEN TS COMPOSITION IN A GROUP OF NON ALCOHOLIC REFRESHMENTS

      Medicina Clinica
    33. FILELLA X; AIBAR C; MOLINA R; BALLESTA AM; GORDON K; DILLON P; NORTON A; CARPENTER WR
      CLINICAL-EVALUATION OF A FULLY AUTOMATED DIRECT IMMUNOASSAY FOR THE DETERMINATION OF CA-72-4 ASSAY VALUES IN HUMAN SERUM ON THE BAYER IMMUNO-1(TM) SYSTEM

      Clinical chemistry
    34. BLADE J; FILELLA X; MONTOTO S; BOSCH F; MOLINA R; COCA F; LOPEZGUILLERMO AL; CID J; BALLESTA AM; MONTSERRAT E
      CLINICAL RELEVANCE OF INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) SERUM LEVELS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

      British Journal of Haematology
    35. FILELLA X; ALCOVER J; MOLINA R; RODRIGUEZ A; CARRETERO P; BALLESTA AM
      FREE AND TOTAL PSA IN THE DIAGNOSIS OF PROSTATE-CANCER

      Tumor biology
    36. MOLINA R; JO J; FILELLA X; BRUIX J; CASTELLS A; HAGUE M; BALLESTA AM
      SERUM LEVELS OF C-ERBB-2 (HER-2 NEU) IN PATIENTS WITH MALIGNANT AND NONMALIGNANT DISEASES/

      Tumor biology
    37. FILELLA X; ALCOVER J; MOLINA R; RODRIGUEZ A; CARRETERO P; BALLESTA AM
      CLINICAL-EVALUATION OF FREE PSA TOTAL PSA (PROSTATE-SPECIFIC ANTIGEN)RATIO IN THE DIAGNOSIS OF PROSTATE-CANCER

      European journal of cancer
    38. GIL MJ; ALLEPUZ C; RIOJA LA; SERVET HM; FILELLA X; MOLINA R; BALLESTA AM; TALLADA M; COZAR JM; DELASNIEVES HV; ARRUZA A; PERTUSA C; CRUCES H; FLORES N; ZUBIAUR C; BASURTO H; BALLESTEROS JJ; ESPERANZA H; JIMENEZ JF; SANZ S; LAFE H; GALLEGO J; MINGOL VF; GUAJARDO J; ALIJA J; DEVILANOVA HA; CAMACHO E; GARCIA M; VALME H; SALADIE JM; COMET J; PUJOL HGTI; LEIVA O; RODRIGUEZ A; SOLSONA E; CASANOVA JL; CONCEPCION T; BANARES F; CHICHARRO JA; BURGOS R; GONZALEZ M; GOMEZ F; CANALEJO HJ; SEBASTIAN JL; MILLAN JA; DELCAMINO HV; CARBALLIDO J; DEHIERRO HP; PALAZON J; ORTIZ B; CASERO C; MATERNOINFANTIL H; SALCEDO E; VIDRIALES I; SILVA C; PEREZ B; COROMINAS A; GONZALEZ CM; BLANCO N; ARRIVAS JL; ZULUETA ML; ORTIZ J; HIERRO HP; FOMBELLIDA J; ENGUIDANOS MJ
      A MULTICENTER STUDY ON THE DETECTION OF PROSTATE-CANCER BY DIGITAL RECTAL EXAMINATION AND PROSTATE-SPECIFIC ANTIGEN IN MEN WITH OR WITHOUT URINARY SYMPTOMS

      European urology
    39. PARES A; GUANABENS N; ALVAREZ L; DEOSABA MJM; MONEGAL A; PARIS P; BALLESTA AM; RODES J
      COLLAGEN-RELATED MARKERS OF BONE TURNOVER IN PRIMARY BILIARY-CIRRHOSIS

      Hepatology
    40. CABALLERIA J; GIMENEZ A; ANDREU H; DEULOFEU R; PARES A; CABALLERIA L; BALLESTA AM; RODES J
      ZINC ADMINISTRATION IMPROVES GASTRIC ALCOHOL-DEHYDROGENASE ACTIVITY AND FIRST-PASS METABOLISM OF ETHANOL IN ALCOHOL-FED RATS

      Alcoholism, clinical and experimental research
    41. BLADE J; FILELLA X; MONTOTO S; BOSCH F; MOLINA R; COCA F; LOPEZGUILLERMO A; CID J; BALLESTA AM; MONTSERRAT E
      CLINICAL RELEVANCE OF INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) SERUM LEVELS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

      Blood
    42. ALVAREZ L; PERIS P; PONS F; GUANABENS N; HERRANZ R; MONEGAL A; BEDINI JL; DEULOFEU R; DEOSABA MJM; MUNOZGOMEZ J; BALLESTA AM
      RELATIONSHIP BETWEEN BIOCHEMICAL MARKERS OF BONE TURNOVER AND BONE SCINTIGRAPHIC INDEXES IN ASSESSMENT OF PAGETS-DISEASE ACTIVITY

      Arthritis and rheumatism
    43. DURANY N; CARBALLO E; JOSEPH J; BEDINI JL; BARTRONS R; BALLESTA AM; CARRERAS J
      ACTIVITY OF PHOSPHOGLYCERATE MUTASE AND ITS ISOENZYMES IN SERUM AFTERACUTE MYOCARDIAL-INFARCTION

      JCP. Clinical molecular pathology
    44. MOLINA R; TORRES MD; MORAGAS M; PEREZVILLA J; FILELLA X; JO J; FARRUS B; GIMENEZ N; TRASERRA J; BALLESTA AM
      PROGNOSTIC-SIGNIFICANCE OF SCC ANTIGEN IN THE SERUM OF PATIENTS WITH HEAD AND NECK-CANCER

      Tumor biology
    45. FILELLA X; ALCOVER J; MOLINA R; CARRERE W; CARRETERO P; BALLESTA AM
      USEFULNESS OF PROSTATE-SPECIFIC ANTIGEN DENSITY AS A DIAGNOSTIC-TEST OF PROSTATE-CANCER

      Tumor biology
    46. FILELLA X; MOLINA R; BALLESTA AM; GIL MJ; ALLEPUZ C; RIOJA LA; PEREZ B; ESQUERDA A; GUAJARDO J; ZULUETA ML; FLORES N; GALLEGO J; GENOLLA J; ARANBURU I; ARRUZA A; COROMINAS A; PASTOR MC; COMET J; ENGUIDANOS MJ; JIMENEZ J; ORTIZ B; CASANOVA J; SOLSONA E; PALAZON J; SALAS A; BALLESTEROS JJ; VIDRIALES I; LARRODERA ML; LEYVA O; GARCIA C; GONZALEZ M; ORTIZ J; MARCOS ML; CARBALLIDO J; CASERO C; ALONSO A; CHICHARRO JA; MILENA A; GONZALEZ C; CONCEPCION T; SALCEDO E; SEBASTIAN JL; BLANCO N; CANADAS E; COZAR JM; SILVA C; CRUZ M; CAMACHO E
      VALUE OF PSA (PROSTATE-SPECIFIC ANTIGEN) IN THE DETECTION OF PROSTATE-CANCER IN PATIENTS WITH UROLOGICAL SYMPTOMS - RESULTS OF A MULTICENTER STUDY

      European journal of cancer
    47. GUANABENS N; PARES A; ALVAREZ L; DEOSABA MJM; MONEGAL A; PERIS P; BALLESTA AM; RODES J
      COLLAGEN-RELATED MARKERS OF BONE TURNOVER IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS

      Journal of bone and mineral research
    48. FILELLA X; BLADE J; GUILLERMO AL; MOLINA R; ROZMAN C; BALLESTA AM
      CYTOKINES (IL-6,TNF-ALPHA,IL-1-ALPHA) AND SOLUBLE INTERLEUKIN-2 RECEPTOR AS SERUM TUMOR-MARKERS IN MULTIPLE-MYELOMA

      Cancer detection and prevention
    49. PARES A; DEULOFEU R; GIMENEZ A; CABALLERIA L; BRUGUERA M; CABALLERIA J; BALLESTA AM; RODES J
      SERUM HYALURONATE REFLECTS HEPATIC FIBROGENESIS IN ALCOHOLIC LIVER-DISEASE AND IS USEFUL AS A MARKER OF FIBROSIS

      Hepatology
    50. PARES A; GIMENEZ A; DEULOFEU R; ALIE S; CABALLERIA J; BALLESTA AM; RODES J
      ZINC PREVENTS LIVER FIBROGENESIS BY DECREASING HEPATIC IRON ENHANCEMENT IN CARBONTETRACHLORIDE INJURED RATS

      Hepatology
    51. FILELLA X; MOLINA R; ALCOVER J; MENENDEZ V; GIMENEZ N; JO J; CARRETERO P; BALLESTA AM
      PROSTATE-SPECIFIC ANTIGEN-DETECTION BY ULTRASENSITIVE ASSAY IN SAMPLES FROM WOMEN

      The Prostate
    52. FILELLA X; MENENDEZ V; MOLINA R; ALCOVER J; CARRETERO P; BALLESTA AM
      TPA PROGNOSTIC VALUE IN SUPERFICIAL BLADDER-CANCER

      Anticancer research
    53. MOLINA R; JO J; FILELLA X; ZANON G; PAHISA J; MUNOZ M; FARRUS B; LATRE ML; GIMENEZ N; HAGE M; ESTAPE J; BALLESTA AM
      C-ERBB-2 ONCOPROTEIN IN THE SERA AND TISSUE OF PATIENTS WITH BREAST-CANCER - UTILITY IN PROGNOSIS

      Anticancer research
    54. CASALS E; FORTUNY A; GRUDZINSKAS JG; SUZUKI Y; TEISNER B; COMAS C; SANLLEHY C; OJUEL J; BORRELL A; SOLER A; BALLESTA AM
      FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN-SYNDROME WITH THE USE OF PAPP-A, AFP, AND BETA-HCG

      Prenatal diagnosis
    55. FILELLA X; MOLINA R; ALCOVER J; CARRETERO P; BALLESTA AM
      DETECTION OF NONPROSTATIC PSA IN SERUM AND NONSERUM SAMPLES FROM WOMEN

      International journal of cancer
    56. MOLINA R; JO J; ZANON G; FILELLA X; FARRUS B; MUNOZ M; LATRE ML; PAHISA J; VELASCO M; FERNANDEZ P; ESTAPE J; BALLESTA AM
      UTILITY OF C-ERBB-2 IN TISSUE AND IN SERUM IN THE EARLY DIAGNOSIS OF RECURRENCE IN BREAST-CANCER PATIENTS - COMPARISON WITH CARCINOEMBRYONIC ANTIGEN AND CA-15.3

      British Journal of Cancer
    57. BALLESTA AM; MOLINA R; FILELLA X; JO J; GIMENEZ N
      CARCINOEMBRYONIC ANTIGEN IN STAGING AND FOLLOW-UP OF PATIENTS WITH SOLID TUMORS

      Tumor biology
    58. ALVAREZ L; GUANABENS N; PERIS P; MONEGAL A; BEDINI JL; DEULOFEU R; DEOSABA MJM; MUNOZGOMEZ J; RIVERAFILLAT F; BALLESTA AM
      DISCRIMINATIVE VALUE OF BIOCHEMICAL MARKERS OF BONE TURNOVER IN ASSESSING THE ACTIVITY OF PAGETS-DISEASE

      Journal of bone and mineral research
    59. DEULOFEU R; GIMENEZ A; ALIE S; CABALLERIA J; BALLESTA AM; RODES J
      EFFECTS OF DIETARY ZINC ON VITAMIN-A LEVELS AND HEPATIC FIBROGENIC ACTIVIN IN ALCOHOLIC RATS

      Hepatology
    60. MOLINA R; TORRES MD; MORAGAS M; FILELLA X; JO J; GIMENEZ N; TRASERRA J; BALLESTA AM
      PROGNOSTIC VALUE OF TPS IN PATIENTS WITH HEAD AND NECK MALIGNANCIES -COMPARISON WITH SCC

      Anticancer research
    61. MOLINA R; ZANON G; FILELLA X; MORENO F; JO J; DANIELS M; LATRE ML; GIMENEZ N; PAHISA J; VELASCO M; BALLESTA AM
      USE OF SERIAL CARCINOEMBRYONIC ANTIGEN AND CA-15.3 ASSAYS IN DETECTING RELAPSES IN BREAST-CANCER PATIENTS

      Breast cancer research and treatment
    62. FILELLA X; ALCOVER J; MOLINA R; GIMENEZ N; RODRIGUEZ A; JO J; CARRETERO P; BALLESTA AM
      CLINICAL USEFULNESS OF FREE PSA FRACTION AS AN INDICATOR OF PROSTATE-CANCER

      International journal of cancer
    63. BEDINI JL; MAS E; DEULOFEU R; MARIN JL; BALLESTA AM
      EVALUATION OF THE ION-SELECTIVE ELECTRODES MODULE IN THE DAX ANALYZERS

      Analytica chimica acta
    64. MOLINA R; AGUSTI C; FILELLA X; JO J; JOSEPH J; GIMENEZ N; BALLESTA AM
      STUDY OF A NEW TUMOR-MARKER, CYFRA-21-1, IN MALIGNANT AND NONMALIGNANT DISEASES

      Tumor biology
    65. FILELLA X; MOLINA R; PIQUE JM; GARCIAVALDECASAS JC; GRAU JJ; NOVELL F; ASTUDILLO E; DELACY A; DANIELS M; BALLESTA AM
      USE OF CA-19-9 IN THE EARLY DETECTION OF RECURRENCES IN COLORECTAL-CANCER - COMPARISON WITH CEA

      Tumor biology
    66. FILELLA X; FUSTER J; MOLINA R; GRAU JJ; GARCIAVALDECASAS JC; GRANDE L; ESTAPE J; BALLESTA AM
      TAG-72, CA-19.9 AND CEA AS TUMOR-MARKERS IN GASTRIC-CANCER

      Acta oncologica
    67. CABALLERIA J; GASSO M; CORRALES F; RUBIO M; DEULOFEU R; GIMENEZ A; PARES A; BALLESTA AM; MATO JM; RODES J
      PROTECTIVE EFFECT OF S-ADENOSYL-L-METHIONINE (SAME) IN THE DEVELOPMENT OF CCL4-INDUCED CIRRHOSIS

      Hepatology
    68. FILELLA X; MOLINA R; PIQUE JM; GRAU JJ; GARCIAVALDECASAS JC; BIETE A; NOVELL F; ASTUDILLO E; BORDAS JM; CAMPO E; DELACY A; DANIELS M; BALLESTA AM
      CEA AS A PROGNOSTIC FACTOR IN COLORECTAL-CANCER

      Anticancer research
    69. ALVAREZ L; GUANABENS N; DEOSABA MJM; PERIS P; MONEGAL A; PALLARES M; MUNOZGOMEZ J; RIVERA F; BALLESTA AM
      BIOCHEMICAL MARKERS OF BONE TURNOVER IN PAGET DISEASE

      Calcified tissue international
    70. GUANABENS N; ALVAREZ L; PARES A; DEOSABA MJM; MONEGAL A; PERIS P; MUNOZ J; BALLESTA AM; RODES J
      OSTEOPOROSIS IN PRIMARY BILIARY-CIRRHOSIS - USEFULNESS OF THE NEW BIOCHEMICAL MARKERS OF BONE TURNOVER

      Calcified tissue international
    71. MOLINA R; FILELLA X; BALLESTA AM
      TUMORAL MARKERS - THEORY OR REALITY

      Medicina Clinica
    72. MAS EA; BEDINI JL; CARMONA F; CARARACH V; GALLART A; BALLESTA AM
      FALSE-NEGATIVE URINARY PREGNANCY TEST IN A WOMAN WITH A COMBINED PANCREAS-KIDNEY TRANSPLANT

      Clinical chemistry
    73. CALLS J; CASES A; FILELLA X; MOLINA R; REVERT L; BALLESTA AM
      INCREASED SERUM LEVELS OF CA-125 IN PATIENTS WITH NEPHROTIC SYNDROME

      Nefrologia
    74. XAUBET A; AGUSTI C; MOLINA R; FILELLA X; MATEU M; SOLE MT; BALLESTA AM; RODRIGUEZROISIN R
      USEFULNESS OF TUMOR-MARKERS MEASUREMENT IN BRONCHIAL TREE OF PATIENTSWITH BRONCHOGENIC-CARCINOMA

      The American review of respiratory disease


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 01:08:39